Early Clinical Trials Of Targeted Therapies Highlighted At AACR-NCI-EORTC Meeting
FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy
Flavopiridol Plus Cisplatin Tested In Phase II Trial
Trial Combines Drugs Against Blood Vessel Formation
Bevacizumab And Irinotecan May Increase Survival Of GBM
NCI Cooperative Group, Cancer Center Trials Listed
Trending Stories
- As daraxonrasib hits the clinic, Frank McCormick says RAS is bigger than pancreatic cancer
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Cancer leaders play “musical chairs” as executive jobs fill at top cancer centers
Lee replaces Pisters at MD Anderson, Tuveson moves to Duke, and Mitchell is named director at University of Florida - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill









